《嘉德诺Cardinal Health（CAH）2025财年年度报告「NYSE」（英文版）（104页）.pdf》由会员分享，可在线阅读，更多相关《嘉德诺Cardinal Health（CAH）2025财年年度报告「NYSE」（英文版）（104页）.pdf（104页珍藏版）》请在三个皮匠报告上搜索。

1、2025Annual report Fiscal 2025 was another strong year for Cardinal Health.We continued to accelerate our momentum with a relentless focus on driving simplification and operational efficiencies in our core,while investing for long-term growth.Our sustained performance is a result of the progress weve

2、 made against our strategic priorities,as we continue evolving to meet customer and patient needs while driving value creation for our shareholders.Dear Shareholders,Delivered GAAP earnings per share of$6.45 and non-GAAP diluted earnings per share of$8.24,growth of over 9%Grew Pharmaceutical and Spe

3、cialty Solutions segment profit by 12%Achieved$135 million in segment profit and positive cash flow generation within the Global Medical Products and Distribution (GMPD)segment by continued execution of the multi-year improvement planAchieved segment profit growth of 22%for the year for the business

4、es reported as “Other”(Nuclear and Precision Health Solutions,at-Home Solutions and OptiFreight Logistics)Generated operating cash flow and non-GAAP adjusted free cash flow of$2.4 billion and$2.5 billion,respectivelyReturned approximately$1.25 billion to shareholders through dividends and share repu

5、rchasesThis fiscal year,we:Fiscal 2025 financial summary GAAP basis fiscal 2025 Non-GAAP basis fiscal 2025Operating earnings%change$2.3 billion 83%$2.8 billion 15%Revenue%change$222.6 billion(2%)N/ADiluted EPS2%change$6.45 87%$8.24 9%Please see Explanation and Reconciliation of Non-GAAP Financial Me

6、asures in our fiscal 2025 Form 10-K for GAAP to Non-GAAP reconciliations.1 Please find our Investor Day presentation at Attributable to Cardinal Health,Inc.The tremendous progress weve made is the result of our focus on continuous improvement;as we outlined at our Investor Day1 in June,we are seeing